These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5452921)

  • 21. Myocardium stabilization by diphenylhydantoin.
    Wax SD; Webb WR; Ecker RR
    Surg Forum; 1969; 20():164-6. PubMed ID: 4192209
    [No Abstract]   [Full Text] [Related]  

  • 22. Some fundamental actions of antiarrhythmic drugs on the excitability and the contractility of singel myocardial fibers.
    Tritthart H; Fleckenstein B; Fleckenstein A
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):212-9. PubMed ID: 4254279
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of lidocaine, propranolol, and sotalol on ouabain-induced changes in transmembrane potential of canine Purkinje fibers.
    Koerpel BJ; Davis LD
    Circ Res; 1972 Jun; 30(6):681-9. PubMed ID: 5025676
    [No Abstract]   [Full Text] [Related]  

  • 24. [Differential effects of a new anti-arrhythmia agent (propafenon) on the Purkinje and myocardial activity filaments].
    Bolte HD; Bergmann M; Tebbe U
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1239-42. PubMed ID: 1029968
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrophysiological effects of CSA-456 on ventricular muscle fibers.
    Martínez N; Manzanares J; Tamargo J
    Arch Farmacol Toxicol; 1980 Apr; 6(1):1-10. PubMed ID: 7387199
    [No Abstract]   [Full Text] [Related]  

  • 26. Electrophysiological effects of a chemical defibrillatory agent, dibenzepin.
    Amitzur G; el-Sherif N; Gough WB
    Cardiovasc Res; 1990 Oct; 24(10):781-5. PubMed ID: 1982246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of anti-arrhythmia agents of the heart conduction system].
    Kodama I; Anno T
    Nihon Rinsho; 1985 Nov; 43(11):2397-403. PubMed ID: 4087425
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.
    Parmley WW; Braunwald E
    J Pharmacol Exp Ther; 1967 Oct; 158(1):11-21. PubMed ID: 6054071
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: The antiarrhythmic activity of the prostaglandins A2, E2, and F2alpha.
    Kaiser J; Schoelkens B
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R44. PubMed ID: 4276580
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the effects of restacorin and flecainide on various cardiac transmembrane potassium currents.
    Németh M; Virág L; Varró A; Papp JG
    Acta Physiol Hung; 1996; 84(3):317-8. PubMed ID: 9219622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The mechanism of antiarrhythmic action of a new ammonium derivative of lidocaine (LKhT-12-02)].
    Blinov DS; Balashov VP; Sernov LN; Kazachenko VN; Blinova EV; Belova LA; Astashev ME
    Eksp Klin Farmakol; 2006; 69(6):31-3. PubMed ID: 17209461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of bretylium tosylate on the electrophysiologic properties of ventricular muscle and Purkinje fibers.
    Bigger JT; Jaffe CC
    Am J Cardiol; 1971 Jan; 27(1):82-92. PubMed ID: 5099592
    [No Abstract]   [Full Text] [Related]  

  • 33. Is the antiarrhythmic effects of PA related to wavelength?
    Tribulova N; Manoach M
    Circulation; 1999 Apr; 99(16):2220-1. PubMed ID: 10217701
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of C3 on the action potential of the cardiac cell. Preliminary results].
    Ferroni A; Sanna GP; Monticelli G
    G Ital Cardiol; 1973 May; 3(5):674-94. PubMed ID: 4771371
    [No Abstract]   [Full Text] [Related]  

  • 35. Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.
    Kirchhof P; Degen H; Franz MR; Eckardt L; Fabritz L; Milberg P; Läer S; Neumann J; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2003 Apr; 305(1):257-63. PubMed ID: 12649377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 37. Cholinergic actions in the sinoatrial node of the reserpine-pretreated rabbit.
    Toda N
    J Pharmacol Exp Ther; 1968 Feb; 159(2):290-7. PubMed ID: 5638650
    [No Abstract]   [Full Text] [Related]  

  • 38. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of dimethyltrilobine iodide on electrical and mechanical activities of guinea pig papillary muscles and hemodynamics in dogs].
    Wei SY; Zhao GS; Zhao YQ
    Zhongguo Yao Li Xue Bao; 1987 Jul; 8(4):334-6. PubMed ID: 3445776
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of bufetolol and propranolol on active and passive membrane properties of dog papillary muscle.
    Inui J; Imamura H
    Jpn J Pharmacol; 1976 Dec; 26(6):639-47. PubMed ID: 15153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.